![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Plus aucun poste en cours
Fortune : 8 M $ au 31/08/2026
Profil
Jared Gollob worked at Duke University from 2002 to 2007 as Director of the Biologic Therapy Program.
From 2007 to 2018, worked at Alnylam Pharmaceuticals, Inc., serving as Global VP of Medical Affairs and Clinical Development from 2012 to 2018.
From 2018 to 2026, worked at Kymera Therapeutics, Inc. as Chief Medical Officer.
Former jobs include Director-Biologic Therapy Program at Duke University and Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 71 359 ( 0,09% ) | 8 M $ | 31/08/2026 |
Anciens postes connus de Jared Gollob
| Sociétés | Poste | Fin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 27/07/2026 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Formation de Jared Gollob
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
